"Immunity, Innate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS.
| Descriptor ID |
D007113
|
| MeSH Number(s) |
G12.450.564
|
| Concept/Terms |
Immunity, Innate- Immunity, Innate
- Immunity, Non-Specific
- Immunity, Non Specific
- Non-Specific Immunity
- Innate Immune Response
- Immune Response, Innate
- Immune Responses, Innate
- Innate Immune Responses
- Immunity, Native
- Native Immunity
- Innate Immunity
- Immunity, Natural
- Natural Immunity
|
Below are MeSH descriptors whose meaning is more general than "Immunity, Innate".
Below are MeSH descriptors whose meaning is more specific than "Immunity, Innate".
This graph shows the total number of publications written about "Immunity, Innate" by people in this website by year, and whether "Immunity, Innate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 2 | 3 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 2 | 2 |
| 1999 | 1 | 3 | 4 |
| 2000 | 0 | 5 | 5 |
| 2001 | 0 | 9 | 9 |
| 2002 | 0 | 4 | 4 |
| 2003 | 2 | 8 | 10 |
| 2004 | 6 | 7 | 13 |
| 2005 | 5 | 13 | 18 |
| 2006 | 6 | 12 | 18 |
| 2007 | 15 | 6 | 21 |
| 2008 | 16 | 12 | 28 |
| 2009 | 12 | 11 | 23 |
| 2010 | 9 | 20 | 29 |
| 2011 | 20 | 13 | 33 |
| 2012 | 21 | 18 | 39 |
| 2013 | 17 | 13 | 30 |
| 2014 | 21 | 12 | 33 |
| 2015 | 16 | 9 | 25 |
| 2016 | 13 | 22 | 35 |
| 2017 | 11 | 15 | 26 |
| 2018 | 12 | 12 | 24 |
| 2019 | 9 | 18 | 27 |
| 2020 | 13 | 9 | 22 |
| 2021 | 10 | 5 | 15 |
| 2022 | 3 | 8 | 11 |
| 2023 | 1 | 12 | 13 |
| 2024 | 5 | 4 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunity, Innate" by people in Profiles.
-
Chibaya L, DeMarco KD, Lusi CF, Kane GI, Brassil ML, Parikh CN, Murphy KC, Chowdhury SR, Li J, Ma B, Naylor TE, Cerrutti J, Mori H, Diaz-Infante M, Peura J, Pitarresi JR, Zhu LJ, Fitzgerald KA, Atukorale PU, Ruscetti M. Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer. Sci Transl Med. 2024 Aug 28; 16(762):eadj9366.
-
Guney MH, Nagalekshmi K, McCauley SM, Carbone C, Aydemir O, Luban J. IFIH1 (MDA5) is required for innate immune detection of intron-containing RNA expressed from the HIV-1 provirus. Proc Natl Acad Sci U S A. 2024 Jul 16; 121(29):e2404349121.
-
Heneka MT. TREM1 is the new kid on the block for the aging-associated innate immune response and Alzheimer's disease. Nat Immunol. 2024 Jun; 25(6):938-940.
-
Bazzone LE, Zhu J, King M, Liu G, Guo Z, MacKay CR, Kyawe PP, Qaisar N, Rojas-Quintero J, Owen CA, Brass AL, McDougall W, Baer CE, Cashman T, Trivedi CM, Gack MU, Finberg RW, Kurt-Jones EA. ADAM9 promotes type I interferon-mediated innate immunity during encephalomyocarditis virus infection. Nat Commun. 2024 May 16; 15(1):4153.
-
Castro-Gomez S, Heneka MT. Innate immune activation in neurodegenerative diseases. Immunity. 2024 Apr 09; 57(4):790-814.
-
Agrawal S. Considerations for Creating the Next Generation of RNA Therapeutics: Oligonucleotide Chemistry and Innate Immune Responses to Nucleic Acids. Nucleic Acid Ther. 2024 04; 34(2):37-51.
-
Kim S, Ramalho TR, Haynes CM. Regulation of proteostasis and innate immunity via mitochondria-nuclear communication. J Cell Biol. 2024 03 04; 223(3).
-
Gallucci S. DNA at the center of mammalian innate immune recognition of bacterial biofilms. Trends Immunol. 2024 02; 45(2):103-112.
-
Lovotti M, Mangan MSJ, McManus RM, Shkarina K, Vasconcelos MB, Latz E. Monitoring of Inflammasome Activation of Macrophages and Microglia In Vitro, Part 2: Assessing Inflammasome Activation. Methods Mol Biol. 2024; 2713:431-451.
-
Mostr?m MJ, Yu S, Tran D, Saccoccio FM, Versoza CJ, Malouli D, Mirza A, Valencia S, Gilbert M, Blair RV, Hansen S, Barry P, Fr?h K, Jensen JD, Pfeifer SP, Kowalik TF, Permar SR, Kaur A. Protective effect of pre-existing natural immunity in a nonhuman primate reinfection model of congenital cytomegalovirus infection. PLoS Pathog. 2023 10; 19(10):e1011646.